~~<i id='ECC0284257'><strike id='ECC0284257'><tt id='ECC0284257'><pre id='ECC0284257'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：comprehensive 2025-10-02 17:12:01 Page View：215

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： UK homeowners get some respite as inflation falls by more than anticipated to a 15
Next article： New air purifier tech could be key to improving indoor air quality

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

Johnson & Johnson sues to stop Medicare negotiation

MARKRALSTON/AFPviaGettyImagesWASHINGTON— PharmaceuticalgiantJohnson&JohnsononTuesdaybecamethethi

Heart attack and stroke risk calculators need revising

AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

More hospitals are billing patients as online messages surge

AdobeHealthsystemsdrowninginmessagesfrompatientsaregraspingfornewwaystomanagethedeluge—includingchar